Review
Oncogene (2006) 25, 3818–3822. doi:10.1038/sj.onc.1209558
Liver stem cells and their implication in hepatocellular and cholangiocarcinoma
T Roskams1
1Head Liver Research Unit, Department of Morphology and Molecular Pathology, University of Leuven, Leuven, Belgium
Correspondence: Dr T Roskams, Head Liver Research Unit, Department of Morphology and Molecular Pathology, University of Leuven, Mnderbroederstraat 12, B-3000 Leuven, Belgium. E-mail: tania.roskams@uz.kuleuven.ac.be
Abstract
In the liver, several cell types have the longevity that is needed to be the cell of origin of a cancer: hepatocytes, cholangiocytes and progenitor cells. The latter are located in the most peripheral branches of the biliary tree, the ductules and canals of Hering. The most important risk factors for liver cancer are chronic viral hepatitis B and C and alcoholic and non-alcoholic steatohepatitis. In these and other chronic liver diseases, progenitor cell activation is seen, rendering them a target cell population for carcinogenesis. The degree of activation is positively correlated with the inflammatory activity and the stage of the disease. Recently, it has been shown that in the cirrhotic stage of most chronic liver diseases, the hepatocytes become senescent owing to telomere shortening. This makes it even more plausible that at least part of the hepatocellular carcinomas originate from a progenitor cell. Hepatocellular carcinomas expressing progenitor cell/ductular markers like cytokeratin 19 have a more aggressive clinical course. It is therefore important to recognize this entity.
Keywords:
liver stem cells, liver progenitor cells, hepatocellular carcinoma, cholangiocarcinoma, dysplastic focus, dysplastic nodule
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Modern Pathology Correspondence
Hepatocellular progenitor cell tumor of the gallbladder: a case report and review of the literature
Modern Pathology Correspondence
British Journal of Cancer Original Article
